Prosecution Insights
Last updated: October 04, 2026
Application No. 18/276,753

HYDROGENATED POLYMER COMPOSITION CONTAINING HYDROGENATED CONJUGATED DIENE MODIFIED POLYMER HAVING BORON-CONTAINING FUNCTIONAL GROUP AND METHOD FOR PRODUCING SAME

Non-Final OA §103
Filed
Aug 10, 2023
Priority
Feb 12, 2021 — JP 2021-021143 +1 more
Examiner
HEINCER, LIAM J
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kuraray Co., Ltd.
OA Round
3 (Non-Final)
56%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
804 granted / 1442 resolved
-9.2% vs TC avg
Strong +26% interview lift
Without
With
+26.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
67 currently pending
Career history
1512
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
50.8%
+10.8% vs TC avg
§102
20.6%
-19.4% vs TC avg
§112
15.2%
-24.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1442 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on September 8, 2026 has been entered. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Ikeda et al. (US Pat. 5,571,871). Considering Claim 1: Ikeda et al. teaches a process of preparing a hydrogenated polymer composition comprising a hydrogenated conjugated diene polymer modified with a boron containing functional group (26:35-57), comprising the steps of anionically polymerizing isoprene/a conjugated diene in the presence of butyl lithium/a reactive metal compound to produce a diene polymer with a reactive terminal group (26:35-57), reacting the reactive terminal polymer with a boron ester (26:35-57) that is preferably tripropylborate or tributylborate (6:12-21) to prepare a terminal modified diene polymer with boron containing terminal groups; and hydrogenating the conjugated diene polymer to react the double bonds present in the polymer (26:35-57). The original specification of the instant application teaches propyl and butyl groups as having the claimed Taft steric parameter in Formula (I) (¶0035). Ikeda et al. teaches adding the boron ester with a borate complex (27:20-40) that includes a polar compound such as triethylamine or tetrahydrofuran (27:20-40; 6:4-12). Ikeda et al. does not teach premixing the complex comprising the polar compound with the boron ester. However, the selection of any order of mixing ingredients is prima facie obvious. In re Gibson, 39 F.2d 975, 5 USPQ 230 (CCPA 1930). See MPEP § 2144.04. It would have been obvious to a person of ordinary skill in the art to have mixed the boron ester and borate complex prior to the addition to the polymer, and the motivation to do so would have been, a person of ordinary skill in the art would expect the resultant product to be substantially similar to the product where they are added separately. Response to Arguments Applicant’s arguments with respect to claim 1 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LIAM J HEINCER whose telephone number is (571)270-3297. The examiner can normally be reached M-F 7:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LIAM J HEINCER/Primary Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

Aug 10, 2023
Application Filed
Feb 26, 2026
Non-Final Rejection mailed — §103
May 21, 2026
Response Filed
Jun 10, 2026
Final Rejection mailed — §103
Sep 08, 2026
Request for Continued Examination
Sep 09, 2026
Response after Non-Final Action
Sep 21, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742067
PHENOLIC RESIN COMPOSITIONS AS BINDERS IN REFRACTORY ARTICLES
4y 5m to grant Granted Sep 22, 2026
Patent 12735515
OLEFINIC POLYMER, AND METHOD FOR PREPARING SAME
3y 3m to grant Granted Sep 15, 2026
Patent 12729301
BIODEGRADGRADABLE DEVICES, AND METHODS OF MAKING THE SAME
6y 0m to grant Granted Sep 08, 2026
Patent 12723133
RESIN BEADS, METHOD FOR PRODUCING RESIN BEADS, AND PRODUCT USING RESIN BEADS
2y 6m to grant Granted Sep 01, 2026
Patent 12714982
Super Absorbent Polymer
1y 10m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
56%
Grant Probability
82%
With Interview (+26.0%)
3y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1442 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month